VHL vitasora health limited

After selling Pathway Oncology and AKTivate to VHL for lofty...

  1. 1,219 Posts.
    lightbulb Created with Sketch. 599
    After selling Pathway Oncology and AKTivate to VHL for lofty sums does Paul Hopper really need/deserve to have his directorial pay doubled to $180k.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.8¢
Change
0.002(7.69%)
Mkt cap ! $48.11M
Open High Low Value Volume
2.7¢ 2.8¢ 2.7¢ $44.61K 1.648M

Buyers (Bids)

No. Vol. Price($)
2 579398 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 2318208 1
View Market Depth
Last trade - 15.52pm 29/07/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.